New Organoselenium Compound Shows Promise Against Aggressive Breast Cancer
A newly synthesized nitro-substituted organoselenium compound, diselenide 7, has been found to reduce the invasiveness of aggressive triple-negative breast cancer cells by modulating various signaling pathways. Research led by Dr. Asis Bala and Dr. Krishna P. Bhabak demonstrated that this compound significantly decreased tumor volume and extended lifespan in mice with breast adenocarcinoma by targeting critical growth pathways and inducing cell death.
Source: Original Link